Your product page is the first thing a clinic buyer reads and the last thing your regulatory team sees. Most biologics product pages are built by a sales lead and a web agency, so they drift past the listing. This post gives manufacturers and distributors seven rules. Follow them and the page describes the product as the listing does, gives the buyer what they need, and gives counsel a clean page to review.
TLDR: A compliant product page describes the product exactly as the listing does, states intended use in the pathway’s own words, and gives the buyer handling, storage, and documents. It leaves out unsupported indications, outcome imagery, clinic testimonials, “FDA registered” headlines, and superlatives. The best biologics product pages also answer the question buyers rarely ask out loud: how do I market, sell, and explain this? Read on for the seven rules, the mistakes we flag first, and a page that sold hope instead of handling.
Important Note
This article is for educational purposes only and does not constitute legal, medical, or regulatory advice. Marketing strategies discussed should be reviewed by qualified legal counsel before implementation, particularly regarding FDA, FTC, and state-specific advertising regulations. Regen Portal is a marketing and consulting company, not a law firm. Nothing here implies FDA approval of any product or any use. Most cell, tissue and exosome products marketed to patients are not FDA approved, and the few cell-based products the FDA has approved are approved only for specific labeled indications. Nothing here promises a marketing or business outcome. Regulations change and enforcement varies by state. Confirm current requirements with qualified legal and compliance counsel before you act on anything you read here.
Most biologics product pages we review fail in the same three places. The claims overstep. The wording is too complex for the person buying. The graphics are weak. The first problem invites regulatory trouble. The other two quietly lose the sale.
Most pages fail on all three at once. They promise more than the listing supports, in words a practice manager cannot repeat, under a stock photo of a glowing knee. The buyer leaves with a feeling and no facts.
This post gives you seven rules for a page that does the opposite. It works for a 361 HCT/P, a device, or any other regulated product.
Why Biologics Product Pages Fail the Buyer
Biologics product pages fail because they are written for the wrong reader. They aim to impress a physician in a ten-second scan. The real reader is a practice owner or manager doing homework at night, with questions the page never answers.
Most product companies reach clinics by cold email, cold calls, and walk-ins. Most email and calls get ignored, and walk-ins convert poorly. The clinics and doctors who do buy want a lot of research, done on their own time without pressure. Your product page is where that research happens.
The second failure shows up after the sale. When a clinic shows us what a supplier gave them, certificates of analysis and establishment registration are often missing. Just as often the gap is not a document. Nothing says how to market the product, sell it, administer it, or explain to patients that the practice offers it.
A page that closes both gaps does more than stay compliant. It gives the buyer a reason to pick you. First, the rules that sit above the seven.
The Rules Above the Rules: What Shapes a Product Page
Four public documents shape what a biologics product page may say. None was written for marketers. Two come from FDA, one from the FTC, and one from Google. Counsel applies the first three to your product.
Start with labeling. For a 361 HCT/P, 21 CFR 1271.370 sets the labeling requirements. Paragraph (a) says each HCT/P made available for distribution must be labeled “clearly and accurately.” Paragraph (b) lists what the label must show. That includes a distinct identification code, a description of the type of HCT/P, and the expiration date, if any.
Paragraph (c) lists what must be on the label or come with the product, and the storage temperature is on that list. Your page is not the label, but buyers expect to find the same facts there.
Next, registration. FDA’s tissue establishment registration page says establishments that make HCT/Ps regulated solely under section 361 must register and list them. It also says acceptance of a registration and listing is not a finding that the establishment is in compliance. Nor does it mean the HCT/P “is licensed or approved by FDA,” in the page’s own words.
Then the FTC. Its Health Products Compliance Guidance says to read each ad as a whole, not phrase by phrase. It says to assess the “net impression” of all its elements, including images. It also says anecdotes about individual consumer experiences are generally not enough to back claims about a health product’s effects.
Last, Google. Its guidance on helpful content asks whether a page shows first-hand expertise and depth of knowledge. It also asks whether content was made mainly to attract visits from search engines. A page stuffed with condition names to rank is made for the wrong reason.
With those four in view, the seven rules almost write themselves.
Rules 1 to 4: What Goes on Biologics Product Pages
Rule 1: the description matches the listing. Rule 2: intended use is stated in the pathway’s own words. Rule 3: handling and storage sit on the page. Rule 4: documents and training are listed. These four fill the first screen of a good page.
Rule 1 first. The page description should be your listing’s description in plainer words, and nothing more. If the listing names a tissue type and a form, the page names that tissue type and form. A new adjective that is not on the listing is a new claim.
Rule 2 is the one counsel cares about most. For a 361 HCT/P, intended use is homologous use, and the words should track the listing. Words like “repair,” “regenerate,” and a list of conditions describe an effect, not a function, and counsel will usually strike them. Our post on marketing a 361 HCT/P explains how the four criteria read your ads as evidence of intent. Write the sentence with counsel, then never let anyone edit it alone.
Rule 3 is the easiest and the most skipped. Storage temperature, shipping method, thaw or prep steps, and the expiration convention belong on the page. The labeling rule already puts storage temperature on the label or with the product. Showing it on the page also stops the front desk from calling your rep on a Friday.
Rule 4 is where most pages go quiet. List the documents a buyer needs: the certificate of analysis, the establishment registration and listing, chain of custody, and the instructions for use. Say how to get each one. Then list training and support: how to administer, staff education, patient explanation language that counsel has reviewed, and marketing guidance.
Those four rules fill the page. The next three keep things off it.
Rules 5 to 7: What Stays Off the Page
Rule 5: no indication the listing does not support, and no outcome imagery. For a cell product, that also means no mechanism claims, no cell counts per vial, and no white paper or viability study on the page. Rule 6: no clinic testimonials or physician quotes about results. Rule 7: no “FDA registered” headline and no superlatives. Each one is a claim in disguise.
A condition list under the product name is an indication claim. So is a photo of an athlete sprinting or a glowing joint. The FTC reads images as part of the whole ad, so the picture makes the claim even when the copy is careful. Show the product, the packaging, the handling steps, and your facility.
Rule 6 is about borrowed credibility. A clinic saying “our patients love the results” is an outcome claim your company now owns. The FTC says advertisers should not make claims through testimonials that they could not back if they made them directly. A physician quote about how easy the product is to store is operational, and fine with the right disclosure.
Rule 7 is about two words that sound official. “FDA registered clinic” is the credential claim we see most often on regen sites. A supplier page with “FDA Registered” in the banner teaches clinics to write it the same way.
FDA’s own page says registration is not licensure, approval, or a compliance finding. State the fact in a plain sentence, never as a badge. Superlatives like “the purest” or “the gold standard” are claims that need evidence you do not have.
Those are the seven. Here is how pages break them without anyone noticing.
Common Mistakes on Biologics Product Pages
The most common mistake on biologics product pages is not a wild claim. It is a page built for the search engine or the rep, not the buyer. Here are the ones we flag most.
First, the condition keyword page. Someone built one page per condition to rank, each pairing your product with a diagnosis. That is one indication claim per page. It fails Google’s helpful content test too.
Second, the science wall. Screens of mechanism language and citations, and no sentence a practice manager can repeat. For a cell product, that language is also evidence of intended use. Clinics write PRP service pages in plain language for a reason. Your page should hand them words at that level.
Third, the missing document shelf. “Full documentation available on request” reads as “we will make you ask.” Name each document and say how a verified account gets it. If you show a sample, have counsel confirm it carries no cell counts, viability, or potency figures.
Fourth, weak graphics. A page that looks like a 2014 template signals a 2014 operation. The ideas behind conversion-focused clinic sites apply here too: one clear ask, a visible path to the documents, and a phone a person answers.
Fifth, the rep-only page. It says almost nothing, because “the rep will explain it.” But a hallway pitch is the least reviewed sentence in your company. Our guidance on what reps may say exists for that reason. The page should be the script the rep is held to.
One page shows all five at once, so it gets its own section.
A Scenario: The Page That Sold Hope Instead of Handling
Picture a tissue product company in its second year. The listing describes a covering and structural use, and the regulatory file is clean. A web agency built the product page without reading the listing. Its brief said “make it convert.”
The page opened with “FDA Registered” in the banner, above a runner at sunrise. Below sat eight conditions, each linking to its own page. Clinic quotes talked about “amazing results.” Storage temperature was nowhere, and the certificate of analysis was “available on request.”
Clinics bought. Then one clinic copied the condition list and the banner into its own service page, word for word. Another clinic’s practice manager called the rep on a Friday to ask how to store the product that just arrived.
The fix had an order. Pull the condition pages and the quotes. Move “FDA registered” into a sentence that says what it means. Replace the runner with the product, and put storage, shipping, and thaw steps on the page. Then add the document shelf and a short guide, reviewed by counsel, on how to explain the product. Whether the old page changed the product’s status is a question for counsel.
These are the questions product companies ask us most.
Frequently Asked Questions
Can a Product Page Say the Product Is FDA Registered?
It may state the fact in a sentence, next to what it means, never as a headline or badge. FDA’s registration page says acceptance of a registration and listing does not mean the product is licensed or approved. Write a plain line that the establishment is registered and the product is listed. Let counsel approve the exact wording.
Can We Show a Physician Quote on the Page?
Yes, if the quote is about operations, not outcomes, and any material connection is disclosed. “The training was thorough and the shipping is reliable” is operational. “My patients are walking again” is an outcome claim, and the FTC says anecdotes generally cannot back it. Counsel should read every quote before it goes live.
What Documents Should the Page List?
The certificate of analysis, the establishment registration and listing, chain of custody, the instructions for use, and any handling and storage sheet. Say how to get each one. When a clinic shows us what a supplier gave them, the certificate and the registration are the ones most often missing, so lead with those.
Does One Product Page Work for Every Pathway?
The structure works, but the intended use sentence does not. A 361 HCT/P states homologous use. A device states the indication in the words of its own clearance or approval. A licensed biologic states its licensed indication. Counsel writes that sentence for your pathway, and the rest of the seven rules apply the same way.
How Is This Different From a Clinic Service Page?
A clinic service page sells a visit and must avoid treatment claims for an unapproved product. A product page sells a product to a clinic and must match the listing. The same words get both in trouble. Our guide to clinic exosome page rules shows the clinic side of that line. This post is the supplier side.
Key Takeaways
- Biologics product pages get flagged first for non-compliant claims, wording too complex for the buyer, and weak graphics.
- The product description and the intended use sentence must match the listing. Use the pathway’s own words, and get counsel’s sign-off.
- Handling, storage, and the buyer’s document list belong on the page, because the labeling rule already requires storage details to travel with the product.
- Condition lists, outcome imagery, and clinic testimonials about results are claims, and the FTC reads the page as a whole.
- “FDA registered” is a fact to state in a sentence, never a headline, because FDA says it is not approval or a compliance finding.
- The buyers who ignore cold outreach still read product pages, so the page has to answer how to market, sell, administer, and explain the product.
Want Us to Handle This?
A product page that follows these rules reads quieter than the competition and helps the buyer finish the research they do alone. It also gives the clinic language it can copy without harm, which is the best thing a supplier can hand a customer.
Our website development work builds pages like this for manufacturers and distributors. Then a marketing compliance audit reads what is already live, phrase by phrase, with a lower-risk rewrite for each flag.
PS: Send us the link to your product page and we will review it against these seven rules at no cost.
Email: hello@regenportal.com
YouTube: Subscribe to the channel
About Regen Portal
Regen Portal is a marketing and consulting company built for the regenerative medicine industry. We handle practice consulting, marketing compliance, search engine optimization, content creation, social media management, paid advertising, website development, branding, and AI and ops consulting for clinics, manufacturers, distributors, and independent providers. For more on me and how we work, visit Regen Portal and contact us.
About the Author
Oscar Tellez is the founder of Regen Portal, a marketing and consulting company built for the regenerative medicine industry. He has been in this industry since 2015. He started in medical sales and has worked with PRP since 2016. He has reached hundreds of practices and over 200 doctors through sales, teaching and marketing. He holds a B.S. in Exercise Science and Health Promotion from Florida Atlantic University.
